Construction of a genome-wide high-throughput cloning vector
A whole genome, cloning vector technology, applied in the field of biomedicine, can solve the problems of low cell fusion rate, poor screening method, and difficulty in culturing fused cells.
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment Construction
[0026] Combine below figure 1 , figure 2 , image 3 and Figure 4 , the embodiments of the present invention are described in detail.
[0027] 1. Construction of retroviral recombinant vectors pLPCX-hTERT and pLXN-SV40LT
[0028] Subcloned hTERT from PIRES2-EGFP-hTERT to the EcoRI site of pLPCX to construct the retroviral recombinant vector pLPCX-hTERT; subcloned SV40LT from pMFGSV40tsLT to the EcoRI / BamHI site of pLXN to construct the retroviral recombinant vector pLXN -SV40LT.
[0029] Reagents: pLPCX, pLXSN retroviral vectors are products of Clontech, USA; PIRES2-EGFP-hTERT or pCIneo-hTERT or, SV40DNA (strain 776) are products of Invitrogen, USA; PCR amplification kit and calcium phosphate precipitation transfection kit Purchased from Invitrogen Company in the United States; E.coliDH5-alpha Escherichia coli was preserved as the unit; Endotoxin-free plasmid purification kit was purchased from QIGEN Company in Germany; EcoR I, Not I, BamH I, and endonucleases were from ...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com